Skip to main content
. 2011 Oct 21;7:409–420. doi: 10.2147/TCRM.S24164

Table 6.

number (%) of respondents with local side effects of discomfort and/or pain and their duration after baseline influenza vaccination

Discomfort/pain H1N1p total Not H1N1p total Overall P valueb
Presence
N (NMISSING) 960 (0) 143 (0) 1103 (0)
Discomforta 377 (39.3%) 26 (18.2%) 403 (36.5%) <0.001
Paina 212 (22.1%) 11 (7.7%) 223 (20.2%) <0.001
Discomfort/paina 589 (61.4%) 37 (25.9%) 626 (56.8%) <0.001
None 371 (38.4%) 106 (74.1%) 477 (43.2%)
Duration
N (NMISSING) 901 (59) 138 (5) 1039 (64)
<5 min 32 (3.6%) 2 (1.4%) 34 (3.3%)
>5 min, <1 h 18 (2.0%) 1 (0.7%) 19 (1.8%) <0.001
>1 h, <1 day 47 (5.2%) 5 (3.6%) 52 (5.0%)
>1 day, 278 (30.9%) 16 (11.6%) 294 (28.3%)
<3 days
>3 days 155 (17.2%) 8 (5.8%) 163 (15.7%)
a

Notes: Patients responding some discomfort or some pain (as applicable) to the question: ‘Did you have any pain or discomfort at the injection site.’ Response options were some discomfort, some pain or none. Number (%) of respondents selecting some discomfort, some pain and some discomfort or some pain are displayed;

b

P value from Fisher exact test on the difference in presence of symptoms and duration responses between respondents receiving H1N1p vaccine and those receiving vaccines other than H1N1p (seasonal/seasonal + other).